Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF MARKETING OFFICER | August 30, 2024 | September 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date August 30, 2024 · Filed September 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,843 |
Ending reported balance
After 2024-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-08-30 · Exercise / conversion · Acquired 1,109 · Balance 46,267 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2024-08-30 · Exercise / conversion · Acquired 1,404 · Balance 47,671 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2024-08-30 · Exercise / conversion · Acquired 3,255 · Balance 50,926 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2024-09-03 · Sale · Disposed 2,083 · Balance 48,843 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,658 |
Reported balance
After 2024-08-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-08-30 · Exercise / conversion · Disposed 1,109 · Balance 6,658 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,808 |
Reported balance
After 2024-08-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-08-30 · Exercise / conversion · Disposed 1,404 · Balance 2,808 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,532 |
Reported balance
After 2024-08-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-08-30 · Exercise / conversion · Disposed 3,255 · Balance 19,532 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 969 | $38.55 | $37,354.95 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,031 | $22.30 | $134,491.30 |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002815 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-21-001180 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,600 Underlying: Common Stock · 7,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,000 | $265.02 | $1,855,140.00 |
DisclosureSEC source: 0001179110-21-001180 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,000 | $22.30 | $156,100.00 |
DisclosureSEC source: 0001179110-21-001180 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-21-000392 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,600 Underlying: Common Stock · 3,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,000 | $204.00 | $612,000.00 |
DisclosureSEC source: 0001179110-21-000392 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,000 | $22.30 | $66,900.00 |
DisclosureSEC source: 0001179110-21-000392 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-21-000317 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,600 Underlying: Common Stock · 4,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,000 | $199.80 | $799,200.00 |
DisclosureSEC source: 0001179110-21-000317 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,000 | $22.30 | $89,200.00 |
DisclosureSEC source: 0001179110-21-000317 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-011721 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 Underlying: Common Stock · 2,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $204.00 | $408,000.00 |
DisclosureSEC source: 0001179110-20-011721 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,000 | $22.30 | $44,600.00 |
DisclosureSEC source: 0001179110-20-011721 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-011597 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,600 Underlying: Common Stock · 4,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,000 | $198.66 | $794,640.00 |
DisclosureSEC source: 0001179110-20-011597 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,000 | $22.30 | $89,200.00 |
DisclosureSEC source: 0001179110-20-011597 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 16:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-010860 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,600 Underlying: Common Stock · 2,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 16:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $204.00 | $408,000.00 |
DisclosureSEC source: 0001179110-20-010860 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 16:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,000 | $22.30 | $44,600.00 |
DisclosureSEC source: 0001179110-20-010860 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-010804 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,600 Underlying: Common Stock · 4,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,000 | $194.00 | $776,000.00 |
DisclosureSEC source: 0001179110-20-010804 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,000 | $22.30 | $89,200.00 |
DisclosureSEC source: 0001179110-20-010804 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-010217 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,600 Underlying: Common Stock · 6,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,000 | $222.86 | $1,337,160.00 |
DisclosureSEC source: 0001179110-20-010217 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,000 | $22.30 | $133,800.00 |
DisclosureSEC source: 0001179110-20-010217 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-009488 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,600 Underlying: Common Stock · 6,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,000 | $219.34 | $1,316,040.00 |
DisclosureSEC source: 0001179110-20-009488 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,000 | $22.30 | $133,800.00 |
DisclosureSEC source: 0001179110-20-009488 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-008736 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,600 Underlying: Common Stock · 6,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,000 | $234.07 | $1,404,420.00 |
DisclosureSEC source: 0001179110-20-008736 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 16:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,000 | $22.30 | $133,800.00 |
DisclosureSEC source: 0001179110-20-008736 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-008014 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,600 Underlying: Common Stock · 2,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $204.00 | $408,000.00 |
DisclosureSEC source: 0001179110-20-008014 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,000 | $22.30 | $44,600.00 |
DisclosureSEC source: 0001179110-20-008014 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-007937 · edgar.xml · derivative · entry 4 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,600 Underlying: Common Stock · 4,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $190.00 | $380,000.00 |
DisclosureSEC source: 0001179110-20-007937 · edgar.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $189.90 | $379,800.00 |
DisclosureSEC source: 0001179110-20-007937 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,000 | $22.30 | $89,200.00 |
DisclosureSEC source: 0001179110-20-007937 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 16:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-007712 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,600 Underlying: Common Stock · 2,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 16:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $205.00 | $410,000.00 |
DisclosureSEC source: 0001179110-20-007712 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 16:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,000 | $22.30 | $44,600.00 |
DisclosureSEC source: 0001179110-20-007712 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-007637 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,600 Underlying: Common Stock · 2,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $190.00 | $380,000.00 |
DisclosureSEC source: 0001179110-20-007637 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,000 | $22.30 | $44,600.00 |
DisclosureSEC source: 0001179110-20-007637 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-007345 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,600 Underlying: Common Stock · 2,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $180.00 | $360,000.00 |
DisclosureSEC source: 0001179110-20-007345 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,276 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 16:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,000 | $22.30 | $44,600.00 |
DisclosureSEC source: 0001179110-20-007345 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 16:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 93,597 | $0.00 Strike: $17.99 | $0.00 |
DisclosureSEC source: 0001179110-20-004982 · edgar.xml · derivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,403 Underlying: Common Stock · 93,597 shares Expires 2026-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on January 4, 2017. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.